Mercator Medical (Poland) Today
| MRC Stock | 47.45 0.25 0.52% |
PerformanceWeak
| Odds Of DistressQuite High
|
Mercator Medical is selling at 47.45 as of the 22nd of March 2025; that is 0.52% down since the beginning of the trading day. The stock's lowest day price was 47.15. Mercator Medical has more than 65 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Moving against Mercator Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Mercator Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mercator Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mercator Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Board | Wieslaw Zyznowski |
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Mercator Medical SA (MRC) is traded on Warsaw Stock Exchange in Poland and employs 1,470 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 438.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mercator Medical's market, we take the total number of its shares issued and multiply it by Mercator Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mercator Medical operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 9.77 M outstanding shares.
Mercator Medical generates positive cash flow from operations, but has no cash available
Check Mercator Medical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Mercator Medical SA is USD438.69 Million. Mercator Medical SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.49 % of Mercator Medical SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Mercator Ownership Details
Mercator Medical Risk Profiles
Although Mercator Medical's alpha and beta are two of the key measurements used to evaluate Mercator Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.38 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.49 | |||
| Risk Adjusted Performance | (0.01) |
Mercator Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mercator Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Mercator Medical Corporate Management
Elected by the shareholders, the Mercator Medical's board of directors comprises two types of representatives: Mercator Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mercator. The board's role is to monitor Mercator Medical's management team and ensure that shareholders' interests are well served. Mercator Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mercator Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Monika Zyznowska | VP Board | Profile | |
| Dariusz Krezymon | Member Medical | Profile | |
| Agnieszka Dziewulska | Chief Accountant | Profile | |
| Michal Romanski | Chief Officer | Profile |
Additional Tools for Mercator Stock Analysis
When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.